Telix Pharmaceuticals Limited Cash And Cash Equivalents
Telix Pharmaceuticals Limited (TLPPF) had Cash And Cash Equivalents of $141.87 million as of 2025-12-31, per its 20-F filed 2026-02-20.
Financial Statements › Notes
ifrs-full:CashAndCashEquivalents · last filed 2026-02-20
- 2024-12-31: Cash And Cash Equivalents 710.35M AUD.
- 2023-12-31: Cash And Cash Equivalents 123.24M AUD.
- 2022-12-31: Cash And Cash Equivalents 116.33M AUD.
- 2021-12-31: Cash And Cash Equivalents 22.04M AUD.
AUD
| Period end | Cash And Cash Equivalents |
|---|---|
| 2024-12-31 | 710.35M AUD 20-F · filed 2025-02-24 |
| 2023-12-31 | 123.24M AUD 20-F · filed 2025-02-24 |
| 2022-12-31 | 116.33M AUD 20-F · filed 2025-02-24 |
| 2021-12-31 | 22.04M AUD 20-F · filed 2025-02-24 |
USD
| Period end | Cash And Cash Equivalents |
|---|---|
| 2025-12-31 | $141.87M 20-F · filed 2026-02-20 |
| 2024-12-31 | $440.00M 20-F · filed 2026-02-20 |
| 2023-12-31 | $84.30M 20-F · filed 2026-02-20 |
| 2022-12-31 | $78.78M 20-F · filed 2026-02-20 |